Plasma homocysteine and risk of mild cognitive impairment.

@article{Reitz2009PlasmaHA,
  title={Plasma homocysteine and risk of mild cognitive impairment.},
  author={Christiane Reitz and M. Tang and Joshua Miller and Ralph Green and Jos{\'e} Alejandro Luchsinger},
  journal={Dementia and geriatric cognitive disorders},
  year={2009},
  volume={27 1},
  pages={11-7}
}
BACKGROUND AND OBJECTIVE There are conflicting data relating homocysteine levels to the risk of Alzheimer's disease (AD). We sought to explore whether fasting plasma homocysteine is associated with the risk of mild cognitive impairment (MCI), an intermediate stage to dementia. METHODS Fasting levels of plasma homocysteine were obtained from 678 elderly subjects chosen at random from a cohort of Medicare recipients. There were longitudinal data in 516 subjects without MCI or dementia at… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Circulating biomarkers that predict incident dementia

Alzheimer's Research & Therapy • 2014
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 52 references

Folate, related vitamins and risk of Alzheimer’s disease

JA Luchsinger
Expert Rev Endocrinol Metab 2007; • 2007

Effect of oral vitamin B 12 with or without folic acid on cognitive function in older people with mild vitamin B 12 deficiency : a randomized , placebocontrolled trial

SJ Eussen, LC deGroot, +7 authors WA vanStaveren
Am J Clin Nutr • 2006

Similar Papers

Loading similar papers…